Avobenzone
Anthelios Sx, Capital Soleil (avobenzone) is a small molecule pharmaceutical. Avobenzone was first approved as Anthelios Sx on 2006-07-21. It is used to treat photosensitivity disorders in the USA.
| Trade Name | Anthelios Sx, Capital Soleil |
|---|---|
| Common Name | Avobenzone |
| Indication | photosensitivity disorders |
| Drug Class |
